ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 130 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $29,000 | -76.6% | 7,796 | -81.9% | 0.01% | -75.0% |
| Q4 2017 | $124,000 | -1.6% | 43,096 | +57.4% | 0.03% | +47.4% |
| Q2 2017 | $126,000 | -61.0% | 27,383 | -64.3% | 0.02% | -48.6% |
| Q1 2017 | $323,000 | +107.1% | 76,783 | +103.1% | 0.04% | +85.0% |
| Q4 2016 | $156,000 | -47.8% | 37,800 | +2.4% | 0.02% | -48.7% |
| Q3 2016 | $299,000 | +1561.1% | 36,900 | +1504.3% | 0.04% | +1850.0% |
| Q2 2016 | $18,000 | -94.9% | 2,300 | -94.2% | 0.00% | -95.7% |
| Q2 2015 | $350,000 | – | 39,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |